Esperion Therapeutics
ESPR
#7075
Rank
โ‚น28.80 B
Marketcap
โ‚น146.81
Share price
0.57%
Change (1 day)
42.77%
Change (1 year)

Esperion Therapeutics (ESPR) - Cash on Hand

Cash on Hand as of June 2024 : โ‚น15.88 B

According to Esperion Therapeutics's latest financial reports the company has โ‚น15.88 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Esperion Therapeutics - Cash on Hand chart (from 2000 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚น6.84 B-50.41%
2022-12-31โ‚น13.80 B-28.55%
2021-12-31โ‚น19.32 B-13.2%
2020-12-31โ‚น22.26 B55.8%
2019-12-31โ‚น14.29 B51.05%
2018-12-31โ‚น9.46 B-25.98%
2017-12-31โ‚น12.78 B-11.09%
2016-12-31โ‚น14.37 B1.94%
2015-12-31โ‚น14.10 B110.56%
2014-12-31โ‚น6.69 B80.45%
2013-12-31โ‚น3.71 B940.97%
2012-12-31โ‚น0.35 B329.04%
2011-12-31โ‚น83.11 M
2002-12-31โ‚น2.15 B-36.58%
2001-12-31โ‚น3.39 B3.47%
2000-12-31โ‚น3.27 B1177.03%
1999-12-31โ‚น0.25 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚น64.07 B 303.49%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น102.71 B 546.76%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น595.73 B 3,651.11%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น822.91 B 5,081.61%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น21.81 B 37.38%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น26.00 B 63.74%๐Ÿ‡บ๐Ÿ‡ธ USA